Philip Morris Launches New "IQOS ILUMA i" Series Devices in Japan

PMI by 2FIRSTS.ai
Apr.19.2024
Philip Morris Launches New "IQOS ILUMA i" Series Devices in Japan
Philip Morris Japan has launched the new "IQOS ILUMA i" series devices, available online and in convenience stores nationwide.

According to Japanese media Kakaku, on April 19th, global tobacco giant Philip Morris' Japanese company launched the new "IQOS ILUMA i" series devices, which are now available for purchase online and in convenience stores.

 

According to the media report, since March 2024, the "ILUMA i" series has been available for purchase on the IQOS online store, official IQOS online accounts, and seven IQOS stores nationwide (some Yamada Denki stores, some Bic Camera stores). Starting from April 16th, major chain convenience stores and some tobacco retailers across Japan will also begin selling the product.

 

According to a statement from PMI, convenience stores will mainly sell the "ILUMA i" and "ILUMA i One", while the "ILUMA i Prime" will be exclusively available at 7-11 convenience stores starting from April 16th. All models are available in two colors: micro blue and midnight black.

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
EU to Abstain from WHO Tobacco Treaty Vote Amid Deep Internal Split
The European Union will abstain from voting at the upcoming 11th session of the WHO Framework Convention on Tobacco Control (COP11) in Geneva, following months of internal disagreement over how to regulate tobacco and nicotine products. The decision marks a rare and public fracture in EU health policy, reportedly driven by the European Commission’s hardline anti-tobacco stance.
Nov.18 by 2FIRSTS.ai
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
BAT Expects Around 2% Revenue and Operating Profit Growth in FY25
British American Tobacco (BAT) reaffirmed its 2026 guidance while announcing a £1.3 billion (approximately USD 1.65 billion) share buyback for FY26. The company expects around 2% growth in revenue and adjusted profit from operations for FY25. Accelerating New Category growth, driven by Velo Plus and improving U.S. Vuse performance, is expected to deliver double-digit H2 revenue growth.
Dec.09 by 2FIRSTS.ai
Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Global Tobacco Companies’ Latest Earnings Review: Nicotine Pouch Business Shows Broad Strength, Emerging as a Key Growth Driver
Multiple global tobacco and next-generation nicotine companies reported solid Q3 performance, with the nicotine-pouch category showing broad-based strength across seven firms. Growth was reflected in higher shipment volumes, expanded market coverage, and new product launches. Several companies also reported rising revenue contributions from pouches and continued investment in this fast-growing segment, underscoring its position as a key driver of future growth.
Nov.14
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
2Firsts Exclusive | AVM President Allison Boughner: The U.S. Vape Market Reshapes Under a Regulatory Storm
Amid intensified regulation and sweeping market shifts, the U.S. vaping industry is undergoing a profound transformation. In an exclusive interview with 2Firsts, AVM President Allison Boughner discusses how enforcement is reshaping brands, distribution, products, compliance, and U.S.-based manufacturing.
Oct.20
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
ZYN Nicotine Pouches Seek MRTP Authorization; FDA Sets January Meeting
The U.S. FDA has scheduled a Tobacco Products Scientific Advisory Committee (TPSAC) meeting for January 22, 2026, to review Swedish Match USA’s Modified Risk Tobacco Product (MRTP) applications for 20 ZYN nicotine pouch products. Although the products gained PMTA authorization in early 2025, MRTP approval is required for marketing them with reduced-risk claims.
Nov.24 by 2FIRSTS.ai
Judge Dismisses Some Claims in Arkansas THC Vape Class Action
Judge Dismisses Some Claims in Arkansas THC Vape Class Action
U.S. District Judge Brian S. Miller has dismissed some claims from a proposed class action alleging that vape products contained THC levels above legal limits, while allowing others to proceed. The court rejected warranty and drug liability claims but upheld RICO, negligence, and fraud allegations against multiple defendants.
Nov.11 by 2FIRSTS.ai